Robuta

Sponsor of the Day: Jerkmate
https://globalrare.org/ GRT – Global Rare Therapeutics global raregrttherapeutics https://www.chiesi.com/it/media-hub/comunicati-stampa/elfabrio-approvazione-commissione-europea-somministrazione-quattro-settimane Chiesi Global Rare Diseases e Protalix BioTherapeutics Il regime approvato riduce il carico terapeutico per i pazienti idonei, le loro famiglie e il sistema sanitario, estendendo l’intervallo tra le infusioni global rarechiesidiseasesprotalixbiotherapeutics https://english.ckgsb.edu.cn/knowledge/article/china-dominance-of-rare-earth-and-impact-on-global-market/ Understanding China's Global Rare Earth Power Leverage—CKGSB Knowledge May 19, 2025 - CKGSB analyzes China’s dominance on the rare earth market, its role in tech and defense sectors, and how global economies are preparing alternative strategies. global rareunderstandingchinaearthpower https://raredirectory.com/category/business-global/ Business Global | Rare Directory business globalrare directory https://chiesirarediseases.com/ Chiesi Global Rare Diseases | A Rare Disease Therapeutics Company Chiesi Global Rare Diseases is a family-owned and run biopharmaceutical company with a commitment to providing transformative care to patients with rare... global raredisease therapeuticschiesidiseasescompany https://www.trtworld.com:443/article/b70d1abc13fc Long Read: How rediscovery of rare Rafflesia flower divided global scientific community - TRT World Apr 7, 2026 - For centuries, Western botanists have waded into tropical forests and claimed to have ‘discovered’ unique plants and flowers. Now, local researchers want to... community trt worldlong readglobal scientificrediscoveryrare https://www.rarediseasesinternational.org/event/wha-79-side-event-rare-diseases-a-catalyst-for-global-health-transformation/ WHA 79 Side Event - Rare Diseases: a Catalyst for Global Health Transformation - Rare Diseases... Apr 13, 2026 - Rare diseases expose the stress points of our health systems, revealing gaps in diagnosis, care coordination, innovation, data, financing, and access. More... side eventrare diseasesglobal healthwha79